Cravath, Sullivan & Cromwell Aid J&J’s $17.3 Billion Abiomed Bid

Cravath, Swaine & Moore and Sullivan & Cromwell are guiding Johnson & Johnson’s plan announced Tuesday to purchase heart pump maker Abiomed Inc. for $17.3 billion.

Cravath’s co-heads of the firm’s global mergers and acquisitions practice, Robert Townsend III and George Schoen, along with Sanjay Murti, who became partner at the Wall Street firm in January, led the firm’s J&J team.

Sullivan & Cromwell partner Matthew Hurd and co-head of its capital markets group Robert Downes took the lead on mergers and acquisition matters in the deal. Hurd has advised on several high-profile deals in the life sciences space over ...